نتایج جستجو برای: diphencyprone

تعداد نتایج: 53  

Journal: :Archives of dermatology 2001
M C Wiseman J Shapiro N MacDonald H Lui

BACKGROUND Immunotherapy with diphencyprone (diphenylcyclopropenone) is used in the treatment of alopecia areata (AA). Response rates have varied in the literature. OBJECTIVES To determine the efficacy of diphencyprone therapy for AA in the largest reported cohort of patients; to identify patient and treatment factors predictive of therapeutic success; and to develop a practical model for pre...

2017
Shelley J E Hwang Benjamin Y Kong Shaun Chou Deepal Wakade Matteo S Carlino Pablo Fernandez-Penas

There are reported cases of diphencyprone used in treating cutaneous metastases of melanoma. Here, we report a patient with previous primary melanoma on his left back treated with surgical excision and lymphadenectomy, followed by radiotherapy for the recurrent tumor on the primary site. Despite radiotherapy and treatment with dabrafenib and trametinib, in-transit metastases have developed and ...

Journal: :Acta dermato-venereologica 2000
M W Lee J H Choi K J Sung K C Moon J K Koh

treatment with diphencyprone. Z Hautkr 1984; 59: 1080 ± 1083. 3. Weisshaar E, Neumann H-J, Gollnick H. Successful treatment of disseminated facial verrucae with contact immunotherapy. Eur J Dermatol 1998; 8: 488 ± 491. 4. Greenberg JH, Smith TL, Katz RM. Verrucae vulgares rejection. A preliminary study on contact dermatitis and cellular immune response. Arch Dermatol 1973; 107: 580 ± 582. 5. La...

Journal: :The British journal of dermatology 1996
P M Gordon R D Aldrige E McVittie J A Hunter

Forty-eight patients (23 male, 25 female) with severe alopecia areata were sensitized and treated with topical diphencyprone. Thirty-eight per cent of the subjects had good regrowth of hair at a mean follow-up period of 30.8 months. The presence of nail changes, a personal history of atopy and a long duration of alopecia had an adverse prognostic effect.

Journal: :Dermatology Research and Practice 2010

Journal: :Skin therapy letter 2000
C Bolduc J Shapiro

Topical immunotherapy with diphencyprone (DPCP) for the treatment of severe alopecia areata has been used since 1983 and is felt to be the treatment of choice by many dermatologists. Although there have been no major side effects reported since its initial use, there remain some unknowns regarding its safety. Because DPCP has at least a 40% success rate for cosmetically acceptable regrowth in e...

2017

This issue begins with Australian research showing that wearing superfine merino woollen clothing may help manage children with atopic dermatitis. Researchers from the US have reported that patients with hidradenitis suppurativa have changes in the expression of genes encoding enzymes involved in sphingolipid metabolic pathways. Research from Queensland reports on patients treated with diphenyl...

Journal: :Annals of the Academy of Medicine, Singapore 2009
Jiun Yit Pan Colin Theng Joyce Lee Boon Kee Goh

Dear Editor, Diphencyprone (DCP) is a contact sensitiser used to treat dermatological conditions resulting from an altered immunological state, such as extensive alopecia areata. Adverse effects include local eczema with blistering, regional lymphadenopathy and contact urticaria. Rare adverse effects include an erythema multiforme-like reaction, hyperpigmentation, hypopigmentation and vitiligo....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید